A carborane chiral compound, its preparation method, its optical purity analysis and detection method and application
Through the asymmetric bihydroxylation reaction of carboborane chiral compounds and the cinchonaline biocatalysis, the problems of insufficient enantioselectivity and catalytic performance of existing chiral diols in asymmetric synthesis are solved, and the problem of insufficient enantioselectivity and catalytic performance of existing chiral diols in asymmetric synthesis is achieved. Efficient optical purity detection and catalytic effect, suitable for the synthesis of complex molecules.
Patent Information
- Application Number
- CN202210685433.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2021-07-02
- Filing Date
- 2022-06-15
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-06-15
AI Technical Summary
The enantioselectivity and catalytic properties of existing chiral diols in asymmetric synthesis have not yet achieved the best results, and it is difficult to meet the efficient synthesis needs of complex molecules.
Carbonborane chiral compounds are prepared by asymmetric bihydroxylation reaction, combined with cinchona base derivative catalyst, and can achieve efficient synthesis and detect optical purity by high performance liquid chromatography, and are applied to the field of chiral catalysis.
It improves the enantioselectivity and catalytic properties of carboborane chiral compounds in asymmetric synthesis, achieves efficient optical purity detection and catalytic effects, and is suitable for the synthesis of a variety of complex molecules.
Smart Images

Figure CN115557976B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a carborane chiral compound, a preparation method thereof, an analysis and detection method of its optical purity and application thereof, and belongs to the field of organic synthesis. Background Art
[0002] Chiral compounds refer to compounds with the same molecular weight and molecular structure, but opposite left and right arrangements, such as the real object and its mirror image. Chiral diol compounds are not only widely present in the biological world, but also play a very important role in organic synthesis. Chiral diol compounds are a very widely used chiral ligand in organic catalysis, and are also the starting materials for the preparation of chiral diamines, chiral diphosphines and other compounds.
[0003] Chiral aromatic vicinal diols are chiral compounds with optical properties and are important intermediates for the synthesis of many optically pure drugs. Chiral aromatic vicinal diols contain not only two hydroxyl groups, but also aromatic rings commonly found in drug molecules. They can be used as lead compounds for some drugs through functional group transformation and are important intermediates for many optically pure drugs. They also have wide application value in fine chemical fields such as pesticides, pheromones, fragrance raw materials, and materials. For example, (R)-phenylethylene glycol can be used to prepare β-lactam antibiotics and treat various metabolic problems such as mental disorders. In addition, chiral diols can also be used as chiral ligands, chiral auxiliary agents, and chiral synthetic building blocks in asymmetric synthesis, with good enantioselectivity and catalytic performance. However, the enantioselectivity and catalytic performance of current chiral diols as chiral ligands in asymmetric synthesis need to be improved. Summary of the invention
[0004] The object of the present invention is to provide a carborane chiral compound which has good enantioselectivity and catalytic performance when used as a chiral ligand in asymmetric synthesis.
[0005] The second object of the present invention is to provide a method for preparing a carborane chiral compound.
[0006] The third object of the present invention is to provide a method for analyzing and detecting the optical purity of carborane chiral compounds.
[0007] The fourth object of the present invention is to provide an application of a carborane chiral compound in the field of chiral catalysis.
[0008] The technical solution of the carborane chiral compound of the present invention is:
[0009] A carborane chiral compound, wherein the carborane chiral compound has a structure shown in formula I, II or III,
[0010]
[0011] wherein R1 to R5 are each independently selected from hydrogen, C1-C 20 Alkyl, C1-C 20 Alkoxy, C1-C 20 A fluoroalkyl group or a halo group.
[0012] The carborane chiral compound of the invention has good enantioselectivity and catalytic performance when used as a chiral ligand in asymmetric synthesis.
[0013] Preferably, the C1-C 20 The alkyl group is a C1-C5 alkyl group.
[0014] Preferably, the C1-C 20 The alkoxy group is a C1-C5 alkoxy group.
[0015] Preferably, the C1-C 20 The fluoroalkyl group is a C1-C5 fluoroalkyl group.
[0016] Preferably, only one of R1 to R5 is a C1-C5 alkyl group, a C1-C5 alkoxy group, a C1-C5 fluoroalkyl group or a halo group, and the rest are hydrogen.
[0017] Preferably, the C1-C5 alkyl group is a methyl group or an ethyl group.
[0018] More preferably, the C1-C5 alkyl group is a methyl group.
[0019] The halo group is -F, -Cl, -Br, -I. Preferably, the halo group is -Cl or -F.
[0020] Preferably, R1 and R5 are hydrogen; and R2 to R4 are each independently selected from C1-C5 alkoxy.
[0021] The technical scheme of the preparation method of the carborane chiral compound of the present invention is:
[0022] A method for preparing the chiral carborane compound as described above comprises the following steps: subjecting a reactant M to an asymmetric dihydroxylation reaction to obtain a reactant M having a structure shown in formula A, B or C,
[0023]
[0024] wherein R1 to R5 are each independently selected from hydrogen, C1-C 20 Alkyl, C1-C 20 Alkoxy, C1-C 20 A fluoroalkyl group or a halo group.
[0025] Since Sharpless discovered in 1987 that cinchona alkaloid derivatives can catalyze the asymmetric dihydroxylation reaction of olefins, people have conducted extensive research on the synthesis of chiral diols. In the present invention, the reactant M is subjected to an asymmetric dihydroxylation reaction to obtain the above-mentioned carborane chiral compound. Therefore, the preparation method of the carborane chiral compound of the present invention has the advantages of simple operation, mild preparation conditions and short preparation time of the general dihydroxylation reaction, and is an efficient and environmentally friendly preparation method.
[0026] The olefin in the reactant M of the present invention is a trans structure.
[0027] Preferably, the C1-C 20 The alkyl group is a C1-C5 alkyl group.
[0028] Preferably, the C1-C 20 The alkoxy group is a C1-C5 alkoxy group.
[0029] Preferably, the C1-C 20 The fluoroalkyl group is a C1-C5 fluoroalkyl group.
[0030] Preferably, only one of R1 to R5 is a C1-C5 alkyl group, a C1-C5 alkoxy group, a C1-C5 fluoroalkyl group or a halo group, and the rest are hydrogen.
[0031] Preferably, the C1-C5 alkyl group is a methyl group or an ethyl group.
[0032] More preferably, the C1-C5 alkyl group is a methyl group.
[0033] The halo group is -F, -Cl, -Br, -I. Preferably, the halo group is -Cl or -F.
[0034] Preferably, R1 and R5 are hydrogen; and R2 to R4 are each independently selected from C1-C5 alkoxy.
[0035] The asymmetric dihydroxylation reaction is to convert the olefinic carbon-carbon double bond in the reactant M into a diol. The specific implementation process of the asymmetric dihydroxylation reaction can be completed with reference to the prior art. Preferably, the asymmetric dihydroxylation reaction comprises the following steps: adding the reactant M to a solution containing a catalytic system, performing an asymmetric dihydroxylation reaction, and quenching the reaction after the reaction is completed.
[0036] Preferably, the catalytic system comprises a catalyst, an oxidant, a ligand, a base and a hydrolysis promoter. Under the action of the catalyst and the oxidant, the alkenyl carborane reactant is first oxidized to an ester, and then the generated ester is hydrolyzed under the action of the hydrolysis promoter to obtain a carborane chiral compound.
[0037] In order not to affect the reaction efficiency and the yield and ee value of the product, preferably, the molar ratio of the reactant M, the co-oxidant and the hydrolysis promoter is 1:(1-3):(1-3).
[0038] Preferably, the hydrolysis promoter is methanesulfonamide.
[0039] Preferably, the catalyst is selected from K2OsO4 and / or K2OsO4 hydrate.
[0040] Preferably, the co-oxidant is selected from K3[Fe(CN)6] and / or 4-methylmorphine-N-oxide.
[0041] The ligand is a cinchona alkaloid derivative. Preferably, the ligand is selected from one or any combination of (DHQ)2PHAL, (DHQD)2PHAL, DHQ-IND and DHQD-IND. (DHQ)2PHAL is hydroquinine 1,4 (2,3-naphthyridine) diether, and (DHQD)2PHAL is hydroquinidine 1,4 (2,3-naphthyridine) diether.
[0042] Preferably, the base is selected from one or more of potassium carbonate, sodium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, NaOH, KOH, LiOH, NH4OH, tBuONa, t-BuOK, t-BuOLi, cesium carbonate, triethylamine, diisopropylethylamine, DBU, pyridine and p-dimethylaminopyridine.
[0043] More preferably, the base is potassium carbonate.
[0044] The solution containing the catalyst system is composed of the catalyst system and a solvent. In order to fully dissolve the compounds in the catalyst system, preferably, the solvent in the solution is composed of an organic solvent and water; the volume ratio of the organic solvent to water is 1:(1-3); the organic solvent is selected from one or any combination of tert-butyl alcohol, acetone, dimethyl sulfoxide, and acetonitrile.
[0045] Preferably, the asymmetric dihydroxylation reaction time is 5 to 30 hours.
[0046] More preferably, the asymmetric dihydroxylation reaction time is 8 to 12 hours.
[0047] Preferably, the temperature of the asymmetric dihydroxylation reaction is 0-25°C.
[0048] Preferably, the quenching reaction comprises the following steps: adding sodium bisulfite to the reaction system and stirring for 0.5 h.
[0049] Preferably, the asymmetric dihydroxylation reaction further comprises the following steps: quenching the reaction followed by extraction and drying.
[0050] In order to better extract the reaction product, preferably, the organic solvent used for the extraction is selected from one or any combination of dichloromethane, ethyl acetate and n-butanol.
[0051] The technical solution of the method for analyzing and detecting the optical purity of the chiral carborane compound of the present invention is:
[0052] A method for analyzing and detecting the optical purity of a chiral carborane compound comprises the following steps: performing chromatographic analysis and detection on a sample using high performance liquid chromatography; the sample comprises the chiral carborane compound; the chromatographic analysis conditions comprise: a chromatographic column is a chiral OJ-H or OD-H column, a mobile phase is n-hexane and isopropanol in a volume ratio of (80-95):(5-20), a flow rate is 0.8-1.0 mL / min, and a column temperature is 20-30° C.
[0053] Further preferably, the chromatographic analysis conditions include: the chromatographic column is a chiral OD-H column, the mobile phase is n-hexane and isopropanol in a volume ratio of 95:5, the flow rate is 0.8 mL / min, and the column temperature is 27°C.
[0054] Typically, the prepared chiral compound appears in the form of R-isomer and S-isomer. The optical purity analysis and detection method of the chiral carborane compound of the present invention can achieve accurate quantitative analysis of the optical purity of the R-isomer of the chiral carborane compound.
[0055] Preferably, the high performance liquid chromatography is performed by a high performance liquid chromatograph equipped with an ultraviolet detector; the detection wavelength is 210 nm.
[0056] The technical solution for using the chiral carborane compound of the present invention as a chiral ligand in the field of chiral catalysis is:
[0057] An application of the above carborane chiral compound as a chiral ligand in the field of chiral catalysis.
[0058] The above-mentioned chiral carborane compounds are used as chiral ligands in the field of chiral catalysis, and have good enantioselectivity and catalytic performance. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1 is the hydrogen nuclear magnetic resonance spectrum of the chiral carborane compound (Compound 2a) prepared in Example 12;
[0060] Figure 2 The carbon NMR spectrum of the chiral carborane compound (Compound 2a) prepared in Example 12;
[0061] Figure 3is the NMR boron spectrum of the carborane chiral compound (Compound 2a) prepared in Example 12;
[0062] Figure 4 The single crystal diffraction structure diagram of the chiral carborane compound (Compound 2a) prepared in Example 12;
[0063] Figure 5 This is the high performance liquid chromatogram obtained from the test in Example 23. DETAILED DESCRIPTION
[0064] The technical solution of the present invention is further described below in conjunction with specific implementation methods.
[0065] 1. Specific examples of the carborane chiral compounds of the present invention are as follows:
[0066] Example 1
[0067] The structural formula of the chiral carborane compound (Compound 2a) of this embodiment is as follows:
[0068]
[0069] Example 2
[0070] The structural formula of the chiral carborane compound (Compound 2b) of this embodiment is as follows:
[0071]
[0072] Example 3
[0073] The structural formula of the chiral carborane compound (Compound 2c) of this embodiment is as follows:
[0074]
[0075] Example 4
[0076] The structural formula of the chiral carborane compound (Compound 2d) of this embodiment is as follows:
[0077]
[0078] Example 5
[0079] The structural formula of the chiral carborane compound (Compound 2e) of this embodiment is as follows:
[0080]
[0081] Example 6
[0082] The structural formula of the chiral carborane compound (Compound 2f) of this embodiment is as follows:
[0083]
[0084] Example 7
[0085] The structural formula of the chiral carborane compound (Compound 2g) of this example is as follows:
[0086]
[0087] Example 8
[0088] The structural formula of the chiral carborane compound (Compound 2h) of this embodiment is as follows:
[0089]
[0090] Example 9
[0091] The structural formula of the chiral carborane compound (Compound 2i) of this embodiment is as follows:
[0092]
[0093] Example 10
[0094] The structural formula of the chiral carborane compound (Compound 2j) of this embodiment is as follows:
[0095]
[0096] Embodiment 11
[0097] The structural formula of the chiral carborane compound (Compound 2k) of this example is as follows:
[0098]
[0099] 2. The specific examples of the preparation method of the carborane chiral compound of the present invention are as follows:
[0100] The yields in the following examples of the preparation of chiral carborane compounds (Examples 12-22) are all the yields of the asymmetric dihydroxylation reaction (step 2).
[0101] Example 12
[0102] The preparation method of the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 1 (compound 2a), comprising the following steps:
[0103] (1) Under N2 protection, 66 mg of ground magnesium chips and 25 mL of anhydrous ether were added to the reaction flask, the reaction flask was placed in a 35°C water bath and stirred, then a solution of 1-bromomethylene-o-carborane (500 mg, 2.1 mmol) and 120 mL of anhydrous ether was slowly added dropwise, and the reaction was continued for 3 h at room temperature. After the magnesium chips disappeared, the reaction system was cooled to 0°C and stirred for 20 min. Then, a solution of 4-chlorobenzaldehyde (351 mg, 2.5 mmol) and 90 mL of anhydrous ether was slowly added dropwise, and the reaction was continued for 3 h at 0°C. The reaction product was subjected to reduced pressure distillation to obtain a solid product. Then, under N2 protection, the obtained solid product, p-toluenesulfonic acid (15 mg, 0.1 mmol) and 500 mL of toluene were added to a single-necked flask and refluxed for 14 h. After the reaction was completed, the reaction product was separated by reduced pressure distillation and column chromatography (with petroleum ether as the developing solvent) to obtain compound 1a.
[0104] (2) At 25°C, 9.88 g (0.03 mol) of potassium ferricyanide (K3[Fe(CN)6]), 2.76 g (0.02 mol) of potassium carbonate (K2CO3), 0.05 g (0.15 mmol) of potassium osmate dihydrate (K2OsO4·2H2O) and 0.039 g (0.05 mmol) of hydroquinone 1,4 (2,3-naphthyridine) diether ((DHQ)2·PHAL) were dissolved in 25 mL of tert-butyl alcohol (t-BuOH) and 75 mL of water. The resulting solution was then placed in a reactor and stirred for 10 min. 5.63 g (0.0 2mol) reactant 1a was dissolved in tert-butanol, and then the tert-butanol solution of reactant 1a and 2.85g (0.03mol) methanesulfonamide (CH3SO2NH2) were added to the above reactor, and stirring was continued for 12h; finally, 5.0g sodium bisulfite was added to the reactor, and the mixture was stirred at 25°C for 30min to obtain a reaction product, and then the reaction product was extracted 3 times with 200mL ethyl acetate, the extract was dried with a desiccant (anhydrous sodium sulfate), and then distilled under reduced pressure to remove the solvent to obtain 5.81g of white solid compound 2a with a yield of 92% and an ee value of 97.5%.
[0105] The synthesis route of the chiral carborane compound (Compound 2a) of this embodiment is as follows:
[0106]
[0107] Compound 2a was analyzed by NMR. Figure 1-3 They are the hydrogen spectrum, carbon spectrum and boron spectrum of compound 2a, and the characterization data of compound 2a are as follows:
[0108] Compound 2a, R f=0.17 (hexane / ethyl acetate = 5:1.), melting point: 165-167°C; 1 H NMR (300MHz, CDCl3) δ = 7.41-7.26 (m, 4H), 4.99 (d, J = 4.2Hz, 1H), 4.16-4.03 (m, 2H), 3.24 (d, J = 9.8Hz, 1H), 2.36 (d, J = 4.7Hz, 1H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=138.52,134.54,129.01,127.28,75.50,72.40,57.91; 11 B NMR (128MHz, CDCl3) δ = -3.28 (t, J = 157.9Hz, 3B), -7.19--45.36 (m, 7B).
[0109] The structure of compound 2a was further confirmed by single crystal diffraction. Figure 4 It can be seen that in the single crystal structure, the orderly arrangement of intermolecular hydrogen bonds may be due to the differences between carborane and benzene rings, which leads to the formation of staggered hydrogen bonds between the hydroxyl groups nearby, and the special electronic effect of carborane also strengthens their hydrogen bonding force, providing a preliminary theoretical basis for further studying the stereo transition state-induced chirality of carborane-controlled reactions.
[0110] Embodiment 13
[0111] The preparation method of the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 2 (compound 2b), comprising the following steps:
[0112] (1) Under N2 protection, 38 mg of ground magnesium chips and 12 mL of anhydrous ether were added to the reaction flask, the reaction flask was placed in a 35°C oil bath and stirred, and then a solution of 1-bromomethylene-o-carborane (295 mg, 1.2 mmol) and 90 mL of anhydrous ether was slowly added dropwise. After the addition was complete, the reaction was allowed to react at room temperature for 2.5 h. After the magnesium chips disappeared, the reaction system was cooled to 0°C and stirred for 20 min. Then, a solution of benzaldehyde (148.6 mg, 1.4 mmol) and 45 mL of anhydrous ether was slowly added dropwise. The reaction was continued at 0°C for 3 h. The reaction product was subjected to reduced pressure distillation to obtain a solid product. Then, under N2 protection, the obtained solid product, p-toluenesulfonic acid (12 mg, 0.08 mmol) and 90 mL of toluene were added to a single-necked flask and refluxed for 12 h. After the reaction was completed, the reaction product was separated by reduced pressure distillation and column chromatography (with petroleum ether as the developing solvent) to obtain compound 1b.
[0113] (2) At 0°C, 6.58 g (0.02 mol) of potassium ferricyanide (K3[Fe(CN)6]), 1.38 g (0.01 mol) of potassium carbonate (K2CO3), 0.033 g (0.1 mmol) of potassium osmate dihydrate (K2OsO4·2H2O) and 0.39 g (0.5 mmol) of hydroquinidine 1,4(2,3-naphthyridine) diether ((DHQD)2·PHAL) were dissolved in 25 mL of acetone (CH3COCH3) and 25 mL of water. The resulting solution was then placed in a reactor and stirred for 10 min. 2.46 g (0. 01mol) reactant 1b was dissolved in 25mL acetone, then the acetone solution of reactant 1b and 0.95g (0.01mol) methanesulfonamide (CH3SO2NH2) were added to the above reactor and stirred for 8h; finally, 2.5g sodium bisulfite was added to the reactor and stirred at 25°C for 30min to obtain a reaction product, then the reaction product was extracted 3 times with 200mL dichloromethane, the extract was dried with a desiccant (anhydrous sodium sulfate), and then the solvent was removed by vacuum distillation to obtain 2.49g white solid compound 2b, with a yield of 89% and an ee value of 97%. The synthetic route of the chiral carborane compound (compound 2b) of this embodiment is as follows:
[0114]
[0115] Compound 2b was subjected to NMR analysis, and the characterization data of the obtained compound 2b were as follows:
[0116] Compound 2b, R f =0.23 (hexane / ethyl acetate=5 / 1), melting point: 122-124°C; 1 H NMR (300MHz, CDCl3) δ = 7.45-7.30 (m, 5H), 4.99 (d, J = 3.7Hz, 1H), 4.17 (d, J = 9.5Hz, 1H), 4.09 (s, 1H), 3.28 (d, J = 9.6Hz, 1H), 2.34 (d, J = 4.3Hz, 1H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=140.17,128.87,128.69,125.84,77.54,75.55,73.03,58.08; 11 B NMR (128MHz, CDCl3) δ = -3.33 (t, J = 160.4Hz), -11.31 (dt, J = 406.0, 152.8Hz, 7B).
[0117] Embodiment 14
[0118] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 3 (compound 2c), comprising the following steps:
[0119] (1) Under N2 protection, 1.5 g of polished magnesium chips and 100 mL of anhydrous ether were added to the reaction flask, the reaction flask was placed in a 35°C oil bath with stirring, and then a solution of 1-bromomethylene-o-carborane (10 g, 0.04 mol) and 300 mL of anhydrous ether was slowly added dropwise. After the addition was complete, the reaction was allowed to react at room temperature for 4.5 h. After the magnesium chips disappeared, the reaction system was cooled to 8°C and stirred for 30 min. Then, a solution of 4-methylbenzaldehyde (6 g, 0.05 mol) and 100 mL of anhydrous ether was slowly added dropwise. The reaction was continued at 8°C for 3 h. The reaction product was subjected to reduced pressure distillation to obtain a solid product. Then, under N2 protection, the obtained solid product, p-toluenesulfonic acid (0.6 g, 3.5 mmol) and 500 mL of toluene were added to a single-necked flask and refluxed for 14 h. After the reaction was completed, the reaction product was separated by reduced pressure distillation and column chromatography (with petroleum ether as the developing solvent) to obtain compound 1c.
[0120] (2) At 25°C, 13.17 g (0.04 mol) of potassium ferricyanide (K3[Fe(CN)6]), 4.84 g (0.035 mol) of potassium carbonate (K2CO3), 0.066 g (0.2 mmol) of potassium osmate dihydrate (K2OsO4·2H2O) and 0.078 g (0.1 mmol) of hydroquinone 1,4 (2,3-naphthyridine) diether ((DHQ)2·PHAL) were dissolved in 25 mL of tert-butyl alcohol (t-BuOH) and 75 mL of water. The resulting solution was then placed in a reactor and stirred for 10 min. 7.38 g (0.2 mmol) of potassium carbonate (K2CO3) were added. 1.5g (0.03mol) of reactant 1c was dissolved in 25mL tert-butyl alcohol, and then the tert-butyl alcohol solution of reactant 1c and 2.85g (0.03mol) of methanesulfonamide were added to the above reactor and stirred for 12h; finally, 5.0g of sodium bisulfite was added to the reactor and stirred at 25°C for 30min to obtain a reaction product, and then the reaction product was extracted 3 times with 200mL of ethyl acetate, and the extract was dried with a desiccant (anhydrous sodium sulfate), and then distilled under reduced pressure to remove the solvent to obtain 7.59g of white solid compound 2c, with a yield of 91% and an ee value of 92%. The synthetic route of the chiral carborane compound (compound 2c) of this embodiment is as follows:
[0121]
[0122] Compound 2c was subjected to NMR analysis, and the characterization data of the obtained compound 2c were as follows:
[0123] Compound 2c, R f=0.31 (hexane / ethyl acetate=5 / 1), melting point: 131-133°C; 1 H NMR (300MHz, CDCl3) δ = 7.20 (s, 4H), 4.92 (d, J = 4.1Hz, 1H), 4.14 (d, J = 9.2Hz, 1H), 4.06 (s, 1H), 3.31 (d, J = 9.3Hz, 1H), 2.35 (d, J = 5.1Hz, 4H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=138.64,137.15,129.52,125.79,77.63,75.53,72.92,58.06,21.12; 11 B NMR (128MHz, CDCl3) δ=-0.18--5.63(m,3B),-7.20--16.64(m,7B).
[0124] Embodiment 15
[0125] The preparation method of the chiral carborane compound of this embodiment obtains the chiral carborane compound of Example 4 (Compound 2d), comprising the following steps:
[0126] (1) Under N2 protection, 66 mg of ground magnesium chips and 25 mL of anhydrous ether were added to the reaction flask, the reaction flask was placed in a 35°C water bath and stirred, and then a solution of 1-bromomethylene-o-carborane (500 mg, 2.1 mmol) and 120 mL of anhydrous ether was slowly added dropwise. After the addition was complete, the reaction was continued at room temperature for 3 h. After the magnesium chips disappeared, the reaction system was cooled to 0°C and stirred for 20 min. Then, a solution of 3-methylbenzaldehyde (300 mg, 2.5 mmol) and 90 mL of anhydrous ether was slowly added dropwise. The reaction was continued at 0°C for 3 h. The reaction product was subjected to reduced pressure distillation to obtain a solid product. Then, under N2 protection, the obtained solid product, p-toluenesulfonic acid (15 mg, 0.1 mmol) and 500 mL of toluene were added to a single-necked flask and refluxed for 14 h. After the reaction was completed, the reaction product was separated by reduced pressure distillation and column chromatography (with petroleum ether as the developing solvent) to obtain compound 1d.
[0127] (2) At 25°C, 9.88 g (0.03 mol) of potassium ferricyanide (K3[Fe(CN)6]), 2.76 g (0.02 mol) of potassium carbonate (K2CO3), 0.05 g (0.15 mmol) of potassium osmate dihydrate (K2OsO4·2H2O) and 0.039 g (0.05 mmol) of hydroquinone 1,4 (2,3-naphthyridine) diether ((DHQ)2·PHAL) were dissolved in 25 mL of acetonitrile (CH3CN) and 50 mL of water. The resulting solution was then placed in a reactor and stirred for 10 min. 4.92 g ( 0.02mol) of reactant 1d was dissolved in acetonitrile, and then the acetonitrile solution of 1d and 1.9g (0.02mol) of methanesulfonamide (CH3SO2NH2) were added to the above reactor and stirred for 12h; finally, 5.0g of sodium bisulfite was added to the reactor and stirred at 25°C for 30min to obtain a reaction product, and then the reaction product was extracted 3 times with 200mL of tert-butyl alcohol, and the extract was dried with a desiccant (anhydrous sodium sulfate), and then distilled under reduced pressure to remove the solvent to obtain 4.67g of white solid compound 2d, with a yield of 84% and an ee value of 97%. The synthetic route of the chiral carborane compound (compound 2d) of this embodiment is as follows:
[0128]
[0129] Compound 2d was subjected to NMR analysis, and the characterization data of the obtained compound 2d were as follows:
[0130] Compound 2d, R f =0.29 (n-hexane / ethyl acetate = 5:1), melting point: 124-125°C; 1 H NMR (300MHz, CDCl3) δ = 7.31-7.20 (m, 1H), 7.12 (q, J = 7.7Hz, 3H), 4.91 (s, 1H), 4 .13(d,J=9.1Hz,1H),4.04(s,1H),3.28(d,J=9.3Hz,1H),2.37(d,J=7.3Hz,4H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=140.10,138.70,129.43,128.77,126.45,122.83,77.66,75.51,73.02,58.05,21.44; 11 BNMR (128MHz, CDCl3) δ = -0.25--6.27 (m, 3B), -11.29 (dt, J = 401.1, 153.9Hz, 7B).
[0131] Example 16
[0132] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 5 (compound 2e). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol p-methoxybenzaldehyde. The yield of compound 2e prepared in this embodiment is 74%, and the ee value is 96%. Compound 2e is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2e are as follows:
[0133] Compound 2e: R f =0.19 (hexane / ethyl acetate=3 / 1); 1 H NMR (300MHz, CDCl3) δ = 7.33–7.17 (m, 2H), 6.89 (d, J = 8.6Hz, 2H), 4.89 (s, 1H), 4.1 2(d,J=8.3Hz,1H),4.06(s,1H),3.80(s,3H),3.36(d,J=9.0Hz,1H),2.34(s,1H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=159.82,132.23,127.30,114.21,77.65,75.48,72.74,58.08,55.34; 11 B NMR (128MHz, CDCl3) δ = -3.39 (t, J = 163.0Hz, 3B), -7.20--16.89 (m, 7B).
[0134] Embodiment 17
[0135] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 6 (compound 2f). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol 3,4,5-trimethoxybenzaldehyde. The yield of compound 2f prepared in this embodiment is 76%, and the ee value is 99.5%. Compound 2f is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2f are as follows:
[0136] Compound 2f: R f =0.18 (hexane / ethyl acetate=1 / 1); 1 H NMR (300MHz, CDCl3) δ = 6.42 (s, 2H), 4.84 (s, 1H), 4.18 (d, J = 7.9Hz, 1H), 4.13 (s, 1H), 3.80 (s, 6H), 3.76 (s, 3H), 2.84 (s, 1H), 2.04 (s, 1H); 13 C{ 1H}NMR(75MHz, CDCl3)δ=153.08,137.06,136.64,102.56,77.73,75.19,73.10,60.90,58.08,55.99; 11 B NMR (128MHz, CDCl3) δ = -2.75 (d, J = 154.0Hz, 3B), -7.36--17.19 (m, 7B).
[0137] Embodiment 18
[0138] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 7 (compound 2g). The difference between this embodiment and embodiment 12 is that 2.5mmol 4-chlorobenzaldehyde is replaced by 2.5mmol 3-trifluoromethylbenzaldehyde. The yield of compound 2g prepared in this embodiment is 87%, and the ee value is 95%. Compound 2g is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2g are as follows:
[0139] Compound 2g: R f =0.24 (hexane / ethyl acetate=5 / 1); 1 H NMR (300MHz, CDCl3) δ = 7.62 (s, 2H), 7.52 (dd, J = 3.1, 2.0Hz, 2H), 5.08 (d, J = 3.0Hz, 1H ),4.16(d,J=9.8Hz,1H),4.08(s,1H),3.27(d,J=10.0Hz,1H),2.54(d,J=4.1Hz,1H); 13 C{ 1 H}NMR (75MHz, CDCl3) δ = 141.07, 131.22 (q, J = 32.33Hz), 129.32, 129.27, 125.46 (q, J=3.7Hz),123.8(q,J=270.75Hz),122.73(q,J=3.8Hz),77.20,75.46,72.43,57.91; 11 B NMR (128MHz, CDCl3)δ=-0.87--5.63(m,3B),-7.27--16.48(m,7B); 19 F NMR (376MHz, CDCl3) δ=-62.6.
[0140] Embodiment 19
[0141] The preparation method of the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 8 (compound 2h). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol p-tert-butylbenzaldehyde. The yield of the compound 2h prepared in this embodiment is 88%, and the ee value is 99%. The compound 2h is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2h are as follows:
[0142] Compound 2h: R f =0.29 (hexane / ethyl acetate=5 / 1); 1 H NMR (300MHz, CDCl3) δ = 7.41 (d, J = 8.3Hz, 2H), 7.29 (s, 2H), 4.97 (d, J = 2.3Hz, 1H), 4.17 ( d,J=9.4Hz,1H),4.09(s,1H),3.31(d,J=9.5Hz,1H),2.27(d,J=3.7Hz,1H),1.31(s,9H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=152.04,137.28,125.96,125.79,77.87,75.57,73.02,58.15,34.78,31.41; 11 B NMR (128MHz, CDCl3) δ=-1.12--5.79(m,3B),-7.43--16.48(m,7B).
[0143] Embodiment 20
[0144] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 9 (compound 2i). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol p-trifluoromethylbenzaldehyde. The yield of compound 2i prepared in this embodiment is 87%, and the ee value is 95%. Compound 2i is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2i are as follows:
[0145] Compound 2i: R f =0.22 (hexane / ethyl acetate=5 / 1); 1 H NMR (300MHz, CDCl3) δ = 7.65 (d, J = 8.2Hz, 2H), 7.46 (d, J = 8.2Hz, 2H), 5.08 (d, J = 2.5Hz, 1H), 4.15 (d, J = 9.8Hz, 1H), 4.08 (s, 1H), 3.29 (d, J = 10.0Hz, 1H), 2.60 (d, J = 4.5Hz, 1H);13 C{ 1 H}NMR(75MHz, CDCl3)δ=143.96(d,J=1.2Hz),130.81(q,J=32.4Hz).126.23,125.76(q,J=3.7Hz).123.82(q,J=270.9Hz),77.20,75.50,72.43,57.88; 11 B NMR (128MHz, CDCl3) δ = -3.20 (t, J = 160.6Hz, 3B), -11.84 (dt, J = 252.8, 208.9Hz, 7B); 19 F NMR (376MHz, CDCl3) δ=-62.6.
[0146] Embodiment 21
[0147] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 10 (compound 2j). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol p-fluorobenzaldehyde. The yield of compound 2j prepared in this embodiment is 89%, and the ee value is 97%. Compound 2j is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2j are as follows:
[0148] Compound 2j: R f =0.26 (hexane / ethyl acetate=5 / 1.); 1 H NMR (300MHz, CDCl3) δ=7.34-7.29(m,2H),7.10-7.04(m,2H),4.97(s,1H),4.13(s,1H),4.07(s,1H),3.33(s,1H),2.46(s,1H); 13 C{ 1 H} NMR (75MHz, CDCl3) δ = 164.36, 161.08, 135.91 (d, J = 3.2Hz), 127.71 (d, J = 8.3Hz), 115.78 (d, J = 21.7Hz), 75.52, 72.40, 57.97; 11 B NMR (128MHz, CDCl3) δ = -1.03--5.95(m,3B),-7.04--16.34(m,7B); 19 F NMR (376MHz, CDCl3) δ=-112.9.
[0149] Embodiment 22
[0150] The method for preparing the chiral carborane compound of this embodiment obtains the chiral carborane compound of embodiment 11 (compound 2k). The difference between this embodiment and embodiment 12 is that 2.5 mmol 4-chlorobenzaldehyde is replaced by 2.5 mmol 2-methylbenzaldehyde. The yield of compound 2k prepared in this embodiment is 87%, and the ee value is 99.5%. Compound 2k is subjected to nuclear magnetic resonance analysis, and the characterization data of the obtained compound 2k are as follows:
[0151] Compound 2k: R f =0.26 (hexane / ethyl acetate=5 / 1); 1 H NMR (300MHz, CDCl3) δ=7.42-7.47(m,1H),7.34-7.08(m,3H),5.23(s,1H),4.10(d,J=8.2Hz,1H),3.26(d,J=9.8Hz,1H),2.33(s,3H),2.27(s,1H); 13 C{ 1 H}NMR(75MHz, CDCl3)δ=138.01,133.92,130.90,128.45,126.45,125.52,77.43,73.75,69.44,57.99,19.28; 11 B NMR (128MHz, CDCl3) δ=-0.18--5.95(m,3B),-7.43--16.18(m,7B).
[0152] 3. The specific embodiment of the method for analyzing and detecting the optical purity of the chiral carborane compound of the present invention is as follows:
[0153] Embodiment 23
[0154] This example analyzes and detects the optical purity (ee value) of the chiral carborane compound prepared in Example 12, including the following steps: injecting a methanol solution (concentration of 0.1 g / mL) of the chiral carborane compound prepared in Example 12 into a high performance liquid chromatograph equipped with an ultraviolet detector, and recording a chromatogram; wherein the model of the high performance liquid chromatograph is LC-20A; the chromatographic analysis conditions include: the chromatographic column is a chiral OD-H column (4.6 mm×250 mm), the mobile phase is n-hexane and isopropanol in a volume ratio of 95:5, the flow rate is 0.8 mL / min, and the column temperature is 27°C; the detection wavelength of the ultraviolet detector is 210 nm. The optical purity ee value is obtained by calculation, and the calculation method of the optical purity ee value is as follows:
[0155]
[0156] Wherein: A (S configuration) represents the chromatographic peak area of the S configuration of the enantiomer in the product; A (R configuration) represents the chromatographic peak area of the R configuration of the enantiomer in the product.
[0157] The HPLC chromatogram obtained from the test is as follows: Figure 5 The analysis results of the HPLC are shown in Table 1. It can be calculated that the optical purity of the prepared compound 2a is 97.5%.
[0158] Table 1 Analysis results of HPLC
[0159] Compound Retention time (min) Peak width (min) Peak height (mAU) Peak area (%) R-configuration 7.898 0.5170 628.43134 98.7762 S-configuration 10.403 0.5495 7.37392 1.2238
[0160] 4. Specific examples of the application of the chiral carborane compounds of the present invention as chiral ligands in the field of chiral catalysis are as follows:
[0161] The chiral carborane compound of Example 1, Example 2, Example 3, Example 4, Example 5, Example 6, Example 7, Example 8, Example 9, Example 10 or Example 11 can be used as a chiral ligand in the field of chiral catalysis.
[0162] Experimental example
[0163] The catalytic performance of the catalyst based on the chiral compound (chiral ligand) was evaluated by using the asymmetric addition reaction of aromatic aldehyde and diethylzinc as a template reaction. The specific steps are as follows: Under an argon atmosphere, 0.025mmol of the chiral compound was dissolved in anhydrous tetrahydrofuran, and then 0.25mmol of titanium isopropoxide was added and stirred for 1h to obtain a catalyst based on the chiral compound, and then 2mL of a 1mol / L diethylzinc n-hexane solution was added, and stirred at room temperature for 20min, and finally 0.25mmol of the aromatic aldehyde reactant was added, and the reaction was stirred at room temperature for 24h. After the reaction was completed, the reaction was quenched with 1mL of saturated ammonium chloride solution, and then 25mL of water was added, and then extracted three times with 25mL of ethyl acetate, and the organic phases were combined, and the organic phases were dried over anhydrous sodium sulfate, and then the solvent was removed by reduced pressure distillation to obtain the product chiral aromatic alcohol (R configuration compound). The experimental results are shown in Table 2.
[0164] Table 2 Catalytic performance of catalysts based on different chiral compounds (chiral ligands)
[0165]
[0166] As can be seen from Table 2, the catalyst prepared based on the chiral carborane compound of the present invention has a good catalytic effect on the asymmetric addition reaction of 2-methoxy-benzaldehyde and o-chlorobenzaldehyde with diethylzinc, and its catalytic effect is better than that of other chiral diols (such as the R-isomer of 1,2-di-p-bromophenyl glycol and the R-isomer of 1,2-di-m-bromophenyl glycol); among them, compound 2c has a stronger effect, and its catalytic activity and enantioselectivity for 2-methoxy-benzaldehyde are better than the R-isomer of 1,2-di-p-bromophenyl glycol. It shows that the chiral carborane compound provided by the present invention has good catalytic activity and enantioselectivity, and has potential use in the field of chiral synthesis.
Claims
1. A carborane chiral compound, characterized in that: The carborane chiral compound has a structure shown in Formula I, Among them, R1, R2, R4, and R5 are all hydrogen, and R3 is hydrogen, methyl, -Cl, methoxy, tert-butyl, trifluoromethyl, or -F; or R1, R2, R3, and R4 are all hydrogen, and R5 is methyl; or R1, R2, R3, and R5 are all hydrogen, and R4 is methyl or trifluoromethyl; or R1 and R5 are all hydrogen, and R2, R3, and R4 are all methoxy.
2. A method for preparing a carborane chiral compound as claimed in claim 1, characterized in that: The following steps are involved: The reactant M is added to a solution containing a catalytic system to carry out an asymmetric dihydroxylation reaction, and the reaction is quenched after the reaction is completed; the catalytic system comprises a catalyst, an oxidant, a ligand, a base and a hydrolysis promoter, the hydrolysis promoter is methanesulfonamide, the catalyst is selected from K2OsO4 and / or K2OsO4 hydrate, the oxidant is selected from K3[Fe(CN)6] and / or 4-methylmorphine-N-oxide, and the ligand is a cinchona alkaloid derivative; the reactant M has a structure shown in formula A, Among them, R1, R2, R4, and R5 are all hydrogen, and R3 is hydrogen, methyl, -Cl, methoxy, tert-butyl, trifluoromethyl, or -F; or R1, R2, R3, and R4 are all hydrogen, and R5 is methyl; or R1, R2, R3, and R5 are all hydrogen, and R4 is methyl or trifluoromethyl; or R1 and R5 are all hydrogen, and R2, R3, and R4 are all methoxy.
3. The method for preparing a chiral carborane compound according to claim 2, characterized in that: The molar ratio of the reactant M, the oxidant promoter and the hydrolysis promoter is 1:(1-3):(1-3).
4. A method for analyzing and detecting the optical purity of a chiral carborane compound as claimed in claim 1, characterized in that: The following steps are involved: The samples were subjected to chromatographic analysis using high performance liquid chromatography; The sample comprises the chiral carborane compound as described in claim 1; the chromatographic analysis conditions include: the chromatographic column is a chiral OJ-H or OD-H column, the mobile phase is n-hexane and isopropanol in a volume ratio of (80-95):(5-20), the flow rate is 0.8-1.0 mL / min, and the column temperature is 20-30°C.
5. Use of the chiral carborane compound as claimed in claim 1 as a chiral ligand in the field of chiral catalysis.
